Description

BSE notifies listing of 24,000 equity shares of Himadri Speciality Chemical Ltd issued to Non Promoters on a preferential basis via conversion of warrants, effective February 26, 2026.

Summary

BSE has notified trading members that 24,000 new equity shares of Himadri Speciality Chemical Ltd (Scrip Code: 500184) are listed and permitted to trade on the Exchange with effect from Thursday, February 26, 2026. These shares were issued to Non Promoters on a preferential basis pursuant to the conversion of warrants.

Key Points

  • 24,000 equity shares of Re. 1/- each issued at a premium of Rs. 315/- per share (Issue Price: Rs. 316/-)
  • Issued to Non Promoters on a preferential basis via conversion of warrants
  • New shares rank pari-passu with existing equity shares of the company
  • Distribution Numbers: 504494951 to 504518950
  • ISIN: INE019C01026
  • Date of Allotment: November 10, 2025
  • Effective trading date: February 26, 2026

Regulatory Changes

No new regulatory changes. This is a standard listing notification under BSE’s equity segment procedures for newly allotted securities.

Compliance Requirements

  • Trading members are informed to enable trading in these securities from February 26, 2026 onwards
  • All 24,000 shares are subject to a lock-in period and cannot be freely traded until the lock-in expiry date

Important Dates

  • Date of Allotment: November 10, 2025
  • Trading Effective From: February 26, 2026
  • Lock-in Expiry Date: August 30, 2026 (applicable to all 24,000 shares, Dist. Nos. 504494951 to 504518950)

Impact Assessment

The listing involves a small quantum of 24,000 shares relative to the total equity base of Himadri Speciality Chemical Ltd, resulting in negligible dilution. The shares are subject to a lock-in until August 30, 2026, limiting any immediate market impact. This is a routine corporate action following the preferential allotment approved earlier, with no significant effect on the company’s free float or market liquidity in the near term.

Impact Justification

Routine listing notification for a small allotment of 24,000 equity shares via preferential warrant conversion; minimal dilution impact with a lock-in period until August 2026.